Clinical Traps in Cell Free DNA screening

This podcast regarding cell-free DNA (cfDNA) screening for fetal chromosomal abnormalities. It establishes that cfDNA is the most accurate screening method for common trisomies and should be offered to all pregnant patients regardless of their risk level. The text explains the biological mechanisms behind the technology, such as the analysis of placental DNA fragments, while highlighting the necessity of pretest counseling to manage expectations. Specialized sections address the complexities of screening for sex chromosome aneuploidies, microdeletions, and conditions in twin gestations. Furthermore, the guidelines assist clinicians in interpreting inconclusive results and navigating unexpected findings that may indicate maternal health issues. Overall, the source emphasizes that while cfDNA is a powerful tool, it remains a screening test that requires diagnostic confirmation for definitive results.